4.2.2012
EN
Official Journal of the European Union
C 32/13
Reference for a preliminary ruling from the Landgericht Düsseldorf (Germany), lodged on 16 November 2011 — Novartis AG v Actavis Deutschland GmbH & Co KG, Actavis Ltd.
(Case C-574/11)
2012/C 32/24
Language of the case: German
Referring court
Landgericht Düsseldorf
Parties to the main proceedings
Applicant: Novartis AG
Defendants: Actavis Deutschland GmbH & Co KG, Actavis Ltd.
Question referred
Are Articles 4 and 5 of Regulation (EC) No 469/2009 (1) to be interpreted as meaning that the protection conferred by a supplementary protection certificate, which has been granted for a single active ingredient (in this case, Valsartan), extends to a form which contains a combination of active ingredients featuring that single active ingredient (in this case, Valsartan + Hydrochlorothiazide)?
(1) Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version), OJ 2009 L 152, p. 1.
Full & Egal Universal Law Academy